18F-FDG PET/CT superior to serum CEA in detection of colorectal cancer and its recurrence

Clinical Imaging

Volumn 37, Issue 6, 2013, Pages 1094-1097

  Makis, William ^a   Kurzencwyg, David ^b   Hickeson, Marc ^b  

^a CROSS CANCER INSTITUTE   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Carcinoembryonic antigen; CEA; Colorectal cancer; FDG; PET CT

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CEA; COLORECTAL CANCER; COLORECTAL CANCERS (CRC); FDG; FDG PET; POSITRON EMISSION TOMOGRAPHY (PET);

ANTIGENS; BODY FLUIDS; DISEASES; POSITRON EMISSION TOMOGRAPHY;

COMPUTERIZED TOMOGRAPHY;

CARCINOEMBRYONIC ANTIGEN; FLUORODEOXYGLUCOSE F 18;

ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER STAGING; COLORECTAL CANCER; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; MAJOR CLINICAL STUDY; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

CARCINOEMBRYONIC ANTIGEN; CEA; COLORECTAL CANCER; FDG; PET/CT;

CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FLUORODEOXYGLUCOSE F18; HUMANS; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84887018184     PISSN: 08997071     EISSN: 18734499     Source Type: Journal    
DOI: 10.1016/j.clinimag.2013.04.004     Document Type: Article

References (11)

1. Gold P, Freeman SO Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med 1965, 121:439-462.
2. Wang JY Prognostic significance of pre- and postoperative serum carcinoembryonic antigen levels in patients with colorectal cancer. Eur Surg Res 2007, 39(4):245-250.
3. Desch CE, Benson AB, Somerfield MR Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol 2005, 23:8512-8519.
4. Abdel-Nabi H, Doerr RJ, Lamonica DM, Cronin VR, Galantowicz PJ, Carbone GM, et al. Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxy-glucose whole body PET: correlation with histopathologic and CT findings. Radiology 1998, 206:755-760.
5. 18F-FDG PET/CT in detection of recurrence and metastasis of colorectal cancer. World J Gastroenterol 2007, 13(37):5025-5029.
6. Cohade C, Osman M, Leal J, Wahl R Direct comparison of (18)F-FDG PET and PET/CT in patients with colorectal carcinoma. J Nucl Med 2003, 44:1797-1803.
7. Moertel CG, Fleming TR, McDonald JS, Haller DG, Laurie JA, Tangen C An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 1993, 270(8):943-947.
8. Ito K, Hibi K, Ando H, Hidemura K, Yamazaki T, Akiyama S, et al. Usefulness of analytical CEA doubling time and half-life time for overlooked synchronous metastases in colorectal carcinoma. Jpn J Clin Oncol 2002, 32(2):54-58.
9. Gambhir SS, Czernin J, Schwimmer J, Silverman DHS, Coleman RE, Phelps ME A tabulated summary of the FDG PET literature. J Nucl Med 2001, 42(9):1S-93S. (Suppl.).
10. Votrubova J, Belohlavek O, Jaruskova M, Oliverius M, Lohynska R, Trskova K, et al. The role of FDG-PET/CT in the detection of recurrent colorectal cancer. Eur J Nucl Med Mol Imaging 2006, 33(7):779-784.
11. Kang S, Seo JH, Bae JH, Lee SW, Yoo J, Ahn BC, et al. F-18 FDG PET/CT can detect recurrence earlier than serum CEA level in patients with colorectal cancer after curative surgical resection. J Nucl Med 2007, 48(supplement 2):389P.